Parkside Financial Bank & Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33K	Sell	77 -1	-1%	-$14	﹤0.01%	2318
2026 Q1	$971	Buy	78 +12	+18%	+$161	﹤0.01%	2367
2025 Q4	$832	Hold	66	–	–	﹤0.01%	2400
2025 Q3	$661	Hold	66	–	–	﹤0.01%	2432
2025 Q2	$534	Buy	66 +1	+2%	+$8	﹤0.01%	2510
2025 Q1	$545	Buy	+65	New	+$543	﹤0.01%	2331

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Parkside Financial Bank & Trust's AMRX Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Amneal Pharmaceuticals (AMRX) stake by 1.3% in Q2 2026, selling an estimated $14 and leaving 77 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Parkside Financial Bank & Trust first reported a position in AMRX in Q1 2025 and has held it in 6 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Parkside Financial Bank & Trust held 77 shares of Amneal Pharmaceuticals worth $1.33K as of Q2 2026.
Parkside Financial Bank & Trust sold 1 Amneal Pharmaceuticals share in Q2 2026, an estimated $14.
Amneal Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2318 holding.
Parkside Financial Bank & Trust first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.